Cancer Letters
Volume 197, Issue 1 , Pages 125-130, 18 July 2003

The MYCN oncoprotein as a drug development target

  • Xiaohong Lu

      Affiliations

    • Cancer Research Unit, Northern Institute for Cancer Research, University of Newcastle upon Tyne, Framlington Place, Newcastle-upon-Tyne NE2 4HH, UK
    • ,
  • Andrew Pearson

      Affiliations

    • Sir J. Spence Institute of Child Health, Royal Victoria Infirmary, Queen Victoria Road, Newcastle-upon-Tyne NE1 4LP, UK
    • ,
  • John Lunec

      Affiliations

    • Cancer Research Unit, Northern Institute for Cancer Research, University of Newcastle upon Tyne, Framlington Place, Newcastle-upon-Tyne NE2 4HH, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44-191-222-8532; fax: +44-191-222-7556

Received 31 October 2002; accepted 15 November 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(03)00096-X

doi:10.1016/S0304-3835(03)00096-X

Cancer Letters
Volume 197, Issue 1 , Pages 125-130, 18 July 2003

Article Tools

* Image Usage & Resolution